Alpha Profiles · Company Profile
Aquestive Therapeutics, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/aquestive-therapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: AQST
- Verification
- Partially verified
- Last reviewed
- 2026-10-17T04:46:20.15485+00:00
Overview
Alpha's canonical identity and public leadership record for Aquestive Therapeutics, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
9 public recordsChief Financial Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Chief Innovation and Technology Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Chief Medical Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Chief Operating Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Named Executive Officer / Director
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- AQST DEF 14A executive officersApr 24, 2026
Named Executive Officer
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- AQST DEF 14A executive officersApr 24, 2026
Senior Vice President Regulatory Affairs
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Senior Vice President Information Technology, Human Resources and Communications
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Senior Vice President Sales and Marketing
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AQST executive roster sourceMay 3, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
7 public records- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
- State
- confirmed
- Effective
- From Jan 1, 2007
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
- State
- confirmed
- Effective
- From Jan 1, 2004
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Aquestive Therapeutics, Inc. DEF 14A 2025-04-25Apr 25, 2025
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Timothy E. Morris
- Members
- Timothy E. Morris (Chair)
Compensation
- Chair
- John S. Cochran
- Members
- John S. Cochran (Chair); Timothy E. Morris
Nominating and Governance
- Chair
- Not stated
- Members
- Abigail L. Jenkins; John S. Cochran
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-17T04:46:20.15485+00:00